ARTICLE | Company News
Combinature, Aventis SA deal
July 26, 2004 7:00 AM UTC
Combinature acquired worldwide rights to develop and commercialize a preclinical natural antibiotic product from AVE. Combinature will use its combinatorial biosynthesis to optimize the compound. Comb...